NCT00134940View on ClinicalTrials.gov

Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Coronary Heart Disease
Trial Locations (6)

Unknown

Novarits, Graz

Novartis Investigative Site, Innsbruck

Novartis, Wein

Novartis, Bad Oeynhausen

Novartis Investigative Site, Berlin

Novartis, Erlangen

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00134940 - Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus | Biotech Hunter | Biotech Hunter